Ibutilide is the only Food and Drug Administration-approved intravenous drug for the rapid termination of atrial fibrillation and flutter. Its mechanism of action is undecided. The drug has been ...

New research has identified the specific biological mechanism behind the muscle dysfunction found in myotonic dystrophy type 1 (DM1) and further shows that calcium channel blockers can reverse these ...

New research has identified the specific biological mechanism behind the muscle dysfunction found in myotonic dystrophy type 1 (DM1) and further shows that calcium channel blockers can reverse these ...

Please provide your email address to receive an email when new articles are posted on . CCB users had 39% higher odds of glaucoma on average, as well as thinner inner retinal thickness, vs. non-users.

Alzheimer's disease (AD) is the most common cause of dementia but the changes in brain cell function underlying memory loss remains poorly understood. Researchers at the University of Bristol have ...

Dear Dr. Roach: Does taking Norvasc or any calcium channel blocker reduce or destroy the calcium in the bones, eventually causing osteoporosis? — E.G. Answer: No. Calcium channel blockers, like ...

About The Study: Calcium channel blocker use was adversely associated with glaucoma prevalence in this study of 427,000 adult UK Biobank participants, suggesting that calcium channel blockers may ...

Scientists have long wondered why Parkinson’s disease selectively kills a small group of dopamine-generating neurons. A case is building that these vulnerable neurons, found in the substantia nigra ...

Calcium channel blockers, specifically the short-acting form, appeared associated with increased risk for pancreatic cancer among postmenopausal women, according to a study presented at American ...

Alzheimer's disease (AD) is the most common cause of dementia but the changes in brain cell function underlying memory loss remains poorly understood. Researchers at the University of Bristol have ...

Introduction The clinical management of Obstructive Hypertrophic Cardiomyopathy remains challenging, and the phase III ...

Lowering cholesterol along with blood pressure in patients with hypertension has a lasting impact on survival years after medications have been stopped, new long-term data from the ASCOT Legacy study ...